You're stil a pumping moron. BG had both Abbott and Biomerieux in Europe for years
with a wider indication approved and still no sales. And don't give us that BS about not
being listed on formularies. Abbotts approach is to NOT to rely on government
reimbursement for success. Listen to their past two CC's. We had this discussion
a year ago and you are still wrong. BG destroyed their own company by grinding it to
the ground. Why do you think they are hiding? Pack management
into a bus and drive it off a cliff and no one would miss a thing. Pathetic
apologist for a pathetic company.
It's hard to think that sales will not increase somewhat with ABT now on board. Q4 and Q1 16 will show how fast sales are picking up. Selling at this point is not giving ABT a chance to show us if they are better at sales than BG, and we also have potential FDA clearance of 2nd ind.
Oh my goodness...the forever hopeful. Does it NOT bother you the way they have JACKED up this entire thing? Don't you CARE that you have NO ANSWERS at all from management? Good G-d. Please stop the pumping. We are all really sick and tired and very depressed about getting ripped off.
Years of promises made, promises broken, promises made, promises broken. As the saying goes, fool me once, shame on you; fool me twice, shame on me. At what point do investors acknowledge THEY made a mistake in expecting the next promise will be kept? Cardioscore? Nowhere. Merck deal. Nowhere. Siemens deal. Nowhere. Alere deal? Nowhere? Biomeriux deal? Nowhere. Bioimage? Nowhere. European Sales. Nowhere. US Sales? Down from last year. Did two financings and the stock was still dropped to the OTC...too bad there's not a 12-step problem for BG investors. Step 1: we admitted we were addicted to false prophets (profits)...
Actually series A is not that bad. I spent a couple weeks rummaging through the filings since march. By July I though series A were catastrophically dilutive for retail, it even gave a lot of credence to deliberately driving share prices down since A's could covert at about 22 shares for each A at the historic low of .359 a few weeks ago. Thankfully the august 10-q amended and clarified series A rights. 1:1 conversion no matter what. Anti-Dilution protections ended at the consummation of the Empery offering. So there's no reason to drive SP into the ground. On a buy out, series A should skim no more than 10m off any sale price before the A's join common for the remaining value.
We obviously disagree on Abbott and since that is speculation on my part with no way to back it up I'll just leave it at agreeing to disagree. Your opinion here is as valid as mine :)
Sentiment: Strong Buy
Can you sue for Incompetence? Not sure. Executive management still have a fiduciary responsibility to the shareholder. Maybe the fact that they ran the company down to a 3 million market cap proves incompetence. This is the reverse Robin Hood theory.
Chance of Abbott buying this is ZERO. Will bot happen for sure. If that ever happens, LOL, retail will get nothing. Series A will get preference.
On the "other board" you people give mostly wrong info. I pity the newbies who buy these stocks based on your so called DD. Unfortunately you were sucked in by #1's pumping BGMD on the other board. He hardly knows about trading and his DD is full of wrong info.
Has anything went well with this company? Have they done what they said they would? I am thinking not because if they did we would be on the NASDAQ board...
The last offering was also in part for funds for the G3 launch. That is what they said. So they do have some debt besides the big paychecks they are pulling
out of the company. I feel this is a mute issue because no matter what the
share price has been in a controlled take down. My feeling is to buy the
company back cheap. The last offer was a hatchet job that gave the buyer a
35% premium. Funny those shares never saw the light of retail. You
couple that with the NASDAQ folly and things start to add up. No matter what
happens I don't think retail holders are even a blip on the radar. Think about it
if you bought this stock even 4 months ago you need between $3 to $4 just
to get even. How about the longs holding a year or longer $4 to $6 go back two
years and you need $6 to $8 to get even! You see the last 2 years they
diluted 3 times alone! Plus the R/S split of 1-4 ratio. has caught up to this stock.
They bled it out with almost no money or profit coming in. Do you now see
why I feel like a retail ATM shareholder?
Abbott is never going to buy this ever. Look at Abbott's aquisitions. You must be kidding if you think Abbott is going to buyout a company with a single miserable blood test. Missed on good things? That is the biggest joke ever.
if they have pay all debts, why THAN BK, patrick may be right, however, we indiviual share holder will get nothing, because deal may be at low price